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The Interventional Cardiologist and
Structural Heart Disease
The Need for a Team Approach*
Anthony A. Hilliard, MD, Rick A. Nishimura, MD, FACC
Rochester, MinnesotaThere has been an explosion in the field of inter-
ventional cardiology since Andreas Gruentzig per-
formed the first percutaneous transluminal coronary
angioplasty more than 30 years ago. With the
development of a multitude of steering wires, bal-
loons, rotablators, and stents, percutaneous coro-
nary intervention (PCI) can now be performed in
nearly any patient with coronary artery disease—
“flying solo” by the interventionalist. The interven-
tional cardiologist has now entered into treatment
of structural heart disease. However, as opposed to
therapy of coronary artery disease, catheter-based
therapy of structural heart disease requires a team
approach, with the interventionalist and a noninva-
sive cardiovascular imager collaborating to achieve
optimal success.
See page 1
In patients with coronary disease, it is the
invasive cardiologist who obtains and interprets
the images that determine suitability for PCI.
High-resolution digital imaging, with 2- and
3-dimensional coronary mapping create an excel-
lent road map for the interventional procedure.
Thus, all information required for analysis and
performance of a PCI is under the control of the
interventional cardiologist. Treatment of structural
heart disease is markedly different, as the conven-
tional tools of the invasive cardiologist (fluoroscopy
and hemodynamic pressure measurements) are in-
adequate in this therapeutic arena. Direct imaging
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.From the Division of Cardiovascular Disease, Mayo Clinic College of
Medicine, Rochester, Minnesota.of valvular and myocardial structures is required,
and thus the interventionalist cannot “go it alone.”
Percutaneous mitral balloon valvotomy (PMBV)
was 1 of the first successful catheter-based therapies
for structural heart disease and has now become the
procedure of choice for selected patients with mitral
stenosis. It is essential in this procedure to have the
team approach of the interventionalist and the
noninvasive imager. Not only is a targeted echocar-
diogram of critical importance to select candidates
for PMBV, but simultaneous echocardiography also
is of great utility to guide the procedure and assess
results. Although the latter is not necessarily done
by all laboratories that perform PMBV, this team
approach is certainly utilized by “centers of excel-
lence.” Optimal results require not only a highly
experienced interventionalist, but also a dedicated,
knowledgeable cardiovascular imager.
During the initial evaluation of a patient being
considered for possible PMBV, it is important to
determine the suitability for valvotomy using spe-
cific information from echocardiography (1). The
current assessment of valve morphology used by
many laboratories is a “mitral valve score,” which
incorporates valve mobility, valve calcification, valve
thickening, and the degree of subvalvular fusion (2).
However, the final decision on whether to proceed
with PMBV should not be based only upon a single
number. Inherent in the evaluation is the under-
standing that the mechanism of decreasing gradient
and increasing the mitral valve area by PMBV is
commissural splitting (3). Thus, an important fac-
tor in determining the suitability of the valve for
PMBV is the appearance of the commissures,
assessed by a 2-dimensional echocardiographic
short-axis view. The presence or absence of severe
calcification of 1 or both commissures is an inde-
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9endent determinate of acute success during the
rocedure as well as for the long-term outcome (4).
he emphasis on directly examining the commis-
ures may extend treatment to some patients with
nfavorable scores (e.g., severe leaflet calcification
nd decreased mobility without severe calcification
f the commissures). Other patient subsets whose
esults may not be predicted by a simple score
nclude: 1) the elderly patient with nonrheumatic
itral stenosis caused by annular calcification en-
roaching into the base of the mitral valve leaflet;
nd 2) the patient with severe mitral inflow obstruc-
ion due to severe subvalvular fusion and little
ommissural fusion; neither of these patient subsets
hould undergo PMBV. A full understanding of the
orphologic features and the effect of PMBV on
he entire mitral valve apparatus is thus required by
oth a noninvasive echocardiographer and the in-
erventionalist to determine which patients should
e considered for PMBV.
Once the decision has been made to proceed with
MBV, echocardiography during the procedure is
f great value. In some centers, catheter manipula-
ion is performed primarily under fluoroscopic
uidance, which provides only indirect information.
imultaneous echocardiography (transthoracic or
ransesophageal echocardiography or intravascular
ltrasonography) will directly show the relationship
f the catheter to myocardial structures, and thus
ill aid in optimizing the results of the procedure.
n patients with distorted anatomy due to enlarged
eft atrium, echocardiography can be used to ensure
hat the catheter crosses the level of the fossa ovalis.
ot only does this avoid potential complications
ut also a transseptal puncture through the muscu-
ar portion of the septum may result in difficult
anipulation of the balloon catheter. Echocardiog-
aphy is useful when directing the catheter across
he mitral valve, as the balloon initially tends to
osition at the lateral annulus in the left atrium.
he retraction and counterclockwise rotation of the
atheter required to cross the mitral valve is not
ntuitive based on fluoroscopy but is easily visual-
zed by echocardiography. The echocardiogram can
e used to avoid the complications that occur when
catheter is placed directly into the subvalvular
pparatus and assures that the balloon is properly
eated across the mitral valve, which might not be
vident using fluoroscopy alone. Finally, hemody-
amic evaluation of transmitral gradient and sever-
ty of mitral regurgitation is easily performed by
oppler echocardiography, more accurately than by
atheterization hemodynamics. tThe Inoue balloon has now made it possible to
erform sequentially larger inflations across the
itral valve during the procedure. One of the major
nanswered questions during a PMBV procedure is
when to stop”; e.g., what is the optimal size of the
alloon inflation? The optimal balloon inflation size
ill vary depending not only upon the patient’s size
ut also upon the valve morphology. The conven-
ional approach in most catheterization laboratories
s to sequentially increase the balloon size until
here has been a pre-determined reduction in gra-
ient or increase in mitral valve area. However, if
his approach alone is followed, there may be some
atients in whom severe mitral regurgitation will
evelop and others who will have a suboptimal
esult.
Again, one needs to return to the basic concept
hat the mechanism of successful PMBV is opening
he fused commissures (Fig. 1) The article by
essika-Zeitoun et al. (5) in this issue of iJACC
rovides important outcome data on the value of
ommissural splitting assessed by echocardiogra-
hy. In this large observational study of 875 pa-
ients, those with good immediate PMBV results
mitral valve area 1.5 cm2 and no significant
egurgitation) were divided into 3 groups based
pon the degree of residual commissural fusion
fter the procedure. At 10 years, two-thirds of the
atient population had excellent outcomes (survival
ree of death, mitral surgery, or repeat dilation in
atients with New York Heart Association func-
ional class I to II). However, the 10-year rate of a
ood functional result was 76%, 57%, and only 39%,
espectively, according to complete opening of 2, 1,
r neither commissure. These results, which come
rom a highly experienced team of noninvasive and
nvasive cardiologists, emphasize the importance of
irectly assessing the commissures at the time of the
MBV. Incorporation of all variables (status of
ommissures, valve morphology, transmitral gradi-
nt, left atrial pressure, age, and activity level of
atient) are necessary for joint decisions by the
team” to obtain optimal results from PMBV.
Interventional cardiology is becoming its own
pecialty and rapidly separating itself from the rest
f cardiovascular medicine, as evidenced by its own
ubspecialty boards, separate subspecialty meetings,
nd now even different subspecialty journals (JACC:
ardiovascular Interventions and JACC: Cardiovas-
ular Imaging). However, if an interventionalist
ishes to enter into the arena of the treatment of
tructural heart disease, it is of great importance
hat a “team” be formed with the clinician and
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10oninvasive cardiovascular imager. Acquisition and
nterpretation of cardiac imaging may be outside
he scope of many interventional cardiologists and
utside the capabilities of most catheterization lab-
ratories. Thus, a well-functioning team for diag-
osis and treatment of structural heart disease may
Anterolateral
Commissure
Figure 1. Mechanism of Percutaneous Mitral Balloon Valvotomy
The mechanism of percutaneous mitral balloon valvotomy is the sp
3-dimensional echocardiogram illustrating asymmetric fusion of the
anterolateral commissure after successful percutaneous mitral ballo
dient and improvement in mitral valve area. s/p  status post.lar Angiography and Interventions and ment of commissuraxisting resources—but in the end, that is best for
ptimal patient care and safety.
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g of fused commissures. (Left) Parasternal short-axis view from a
erolateral commissure. (Right) Complete opening of the fused
alvuloplasty (PMBV). This results in a lowering of the diastolic gra-need to be designed and implemented on top of Minnesota 55905. E-mail: rnishimura@mayo.edu.5
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